PART I *** PLEASE READ As I promised I wanted t
Post# of 72440
As I promised I wanted to show iHub readers the last time CTIX was near the current .71 price range. You would have to go WAY back - and I mean WAY back to 2012.
AUGUST 31st 2012 - Closed at .63
September 31st 2012 - Closed at 1.00
In the 10-K released on 10/12/12 I found the below info. Here is link to 10-K (https://www.bamsec.com/filing/154823312000017?cik=1355250)
CASH ON HAND - $27,000
CTIX did not have any major Stock Purchase Agreements at the time! So no funds readily available.
OS as of SEPT 30th 2012 - - 93,124,151 (ONLY 33 MILLION LESS than now)
They had ZERO ongoing CLINICAL trials - just pre-clinical work.
Some notes of accomplishments though:
Jan 2012 - Prurisol Patent Filed
March 2012 - BIDMC Agreement to test Keveterin
May 2012 - Jim Boeheim joined as advisor (lol) Jim is a good man but this was exciting at the time.
June 2012 - IND Meeting with FDA approved to seek section 505(b)(2)
June 2012 - IND approved by FDA to begin Phase 1 trial at Dana Farber and BIDMC for Keveterin
Sept 2012 - Selected Dr. Reddy's Lab to manufacturer P
CTIX owned 8 compounds
________________________________________________________________
Job well done Leo - I must say - to only add 30+ million shares over 5 years and to accomplish what my Part II will discuss... BRAVO!!!